Cullinan Associates Inc Pfizer Inc Transaction History
Cullinan Associates Inc
- $1.81 Billion
- Q3 2024
A detailed history of Cullinan Associates Inc transactions in Pfizer Inc stock. As of the latest transaction made, Cullinan Associates Inc holds 64,904 shares of PFE stock, worth $1.72 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
64,904
Previous 262,084
75.24%
Holding current value
$1.72 Million
Previous $7.33 Million
74.39%
% of portfolio
0.1%
Previous 0.42%
Shares
29 transactions
Others Institutions Holding PFE
# of Institutions
3,261Shares Held
3.62BCall Options Held
77.2MPut Options Held
122M-
Vanguard Group Inc Valley Forge, PA516MShares$13.6 Billion0.27% of portfolio
-
Black Rock Inc. New York, NY424MShares$11.2 Billion0.27% of portfolio
-
State Street Corp Boston, MA290MShares$7.68 Billion0.35% of portfolio
-
Wellington Management Group LLP Boston, MA164MShares$4.33 Billion0.85% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA130MShares$3.44 Billion0.73% of portfolio
About PFIZER INC
- Ticker PFE
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 5,612,349,952
- Market Cap $148B
- Description
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...